Literature citations
Submission
Suzuki Y.; Sugano S.; Totoki Y.; Toyoda A.; Takeda T.; Sakaki Y.; Tanaka A.; Yokoyama S.;
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]; VARIANT VAL-176;
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]; VARIANT VAL-176;
Human glomerular mesangial cells express CD16 and may be stimulated via this receptor.
Morcos M.; Hansch G.M.; Schonermark M.; Ellwanger S.; Harle M.; Heckl-Ostreicher B.;
Kidney Int. 46:1627-1634(1994)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 22-254; VARIANT VAL-176;
Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype.
Koene H.R.; Kleijer M.; Algra J.; Roos D.; von dem Borne A.E.G.K.; de Haas M.;
Blood 90:1109-1114(1997)
Cited for: VARIANT VAL-176; FUNCTION; SUBUNIT;
A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.
Wu J.; Edberg J.C.; Redecha P.B.; Bansal V.; Guyre P.M.; Coleman K.; Salmon J.E.; Kimberly R.P.;
J. Clin. Invest. 100:1059-1070(1997)
Cited for: VARIANT VAL-176;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.